Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Book a demo for a pilot project
Akorn, Inc., a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in the United States. Founded in 1971, the company has established itself as a leader in the development and production of specialty pharmaceuticals, particularly in the areas of ophthalmics, injectables, and other niche markets.
With a strong operational presence across various regions in the US, Akorn is recognised for its commitment to quality and innovation. The company’s core offerings include a diverse range of sterile and non-sterile products, distinguished by their unique formulations and delivery systems.
Akorn has achieved significant milestones, including numerous FDA approvals, which underscore its market position and dedication to advancing healthcare solutions. As a trusted partner in the pharmaceutical sector, Akorn continues to focus on enhancing patient outcomes through its specialised product lines.
-19 vs industry average
Akorn’s score of 23 is lower than 33% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Pharmaceutical Preparation Manufacturing is among the least carbon-intensive industries
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
No reported emissions data is available for Akorn yet.
As Akorn, a pharmaceutical preparation manufacturing company headquartered in the US, does not have publicly available, specific carbon emissions data for recent reporting periods, detailed reporting on their total emissions in kg CO2e is not available. However, the company has outlined climate commitments related to net-zero emissions for its properties.
Akorn's disclosed reduction targets indicate an ambition for net-zero carbon emissions. These include a commitment for new buildings to be net-zero carbon emitters by 2030 and existing buildings by 2050. These targets are positioned as a response to global policy interventions in the property sector. The specific scope of these targets is noted as Scope 1, with a timeframe for new buildings extending to 2030 and for existing buildings to 2050.
No climate goals have been disclosed for Akorn yet.
No scope 3 category breakdown has been disclosed yet.


PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more